Decreased expression of aromatase in the Ishikawa and RL95-2 cells by the isoflavone, puerarin, is associated with inhibition of c-jun expression and AP-1 activity

Food and Chemical Toxicology

Volumn 46, Issue 12, 2008, Pages 3671-3676

  Li, Yanwei ^a   Chen, Huan ^b   Yang, Shengsheng ^b   Xie, Guangru ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AP 1; Aromatase P450; Endometriosis; Pueraria lobata; Puerarin

Indexed keywords

AROMATASE; ISOFLAVONE; PROTEIN C JUN; PUERARIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL LINE; CHINESE MEDICINE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENDOMETRIOSIS; ENDOMETRIUM CANCER; ENZYME ACTIVITY; ESTROGEN THERAPY; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUERARIA;

5' FLANKING REGION; AROMATASE; AROMATASE INHIBITORS; BLOTTING, WESTERN; CELL LINE; DOWN-REGULATION; ENDOMETRIUM; EPITHELIAL CELLS; ESTRADIOL; FEMALE; HUMANS; ISOFLAVONES; LUCIFERASES; PROTO-ONCOGENE PROTEINS C-JUN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

PUERARIA MONTANA VAR. LOBATA;

EID: 55949098220     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.09.045     Document Type: Article

References (29)

1. Almstrup K., Fernandez M.F., Petersen J.H., Olea N., Skakkebaek N.E., and Leffers H. Dual effects of phytoestrogen result in U-shaped dose-response curves. Environ. Health Perspect. 110 (2002) 743-748
2. Berstein L., Zimarina T., Kovalevskij A., Maximov S., Volkov O., and Thijssen J.H. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease. Neoplasma 52 2 (2005) 115-118
3. Bo J., Ming B.Y., Gang L.Z., Lei C., and Jia A.L. Protection by puerarin against MPP+ induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation. Neurosci. Res. 53 2 (2005) 183-188
4. Bulun S.E., Fang Z., Imir G., Gurates B., Tamura M., Yilmaz B., Langoi D., Amin S., Yang S., and Deb S. Aromatase and endometriosis. Semin. Repod. Med. 22 1 (2004) 45-50
5. Bulun S.E., Imir G., Utsunomiya H., Thung S., Gurates B., Tamura M., and Lin Z. Aromatase in endometriosis and uterine leiomyomata. J. Steroid Biochem. Mol. Biol. 95 1-5 (2005) 57-62
6. Bulun S.E., Lin Z., Imir G., Amin S., Demura M., Yilmaz B., Martin R., Utsunomiya H., Thung S., Gurates B., Tamura M., Langoi D., and Deb S. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol. Rev. 57 3 (2005) 359-383
7. Chen Y.P., Higgins J.A., and Gundersen-Rindal D.E. Quantitation of a Glyptapanteles indiensis polydnavirus gene expressed in parasitized host, Lymantria dispar, by real-time quantitative RT-PCR. J. Virol. Meth. 114 2 (2003) 125-133
8. Fatemi H.M., Al-Turki H.A., Papanikolaou E.G., Kosmas L., De sutter P., and Devroey P. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod. Biomed. Online 11 4 (2005) 455-457
9. Huang J.C., Ruan C.H., Tang K., and Ruan K.H. Prunella stica inhibits the proliferation but not the prostaglandin production of Ishikawa cells. Life Sci. 79 5 (2006) 436-441
10. Kazmierczak W., Skalba P., Dabkowska-Huc A., and Samojedny A. Expression of aromatase and 5-alpha-reductase genes in endometrial adenocarcinoma. Pathol. Res. Pract. 202 11 (2006) 789-791
11. Lephart E.D., Setchell K.D., Handa R.J., and Lund T.D. Behavioral effects of endocrine-disrupting substances: phytoestrogens. ILAR J. 45 4 (2004) 443-454
12. Liu Y., and Teng C.T. Identification of the estrogen sensitive marker in human endometrial carcinoma RL95-2 cells. Mol. Cell Endocrinol. 101 1-2 (1994) 167-171
13. Mao C.P., and Gu Z.L. Puerarin reduces increased c-fos, c-jun, and type IV collagen expression caused by high glucose in glomerular mesangial cells. Acta Pharmacol. Sin. 26 8 (2005) 982-986
14. Mazur W., and Adlercreutz H. Overview of naturally occurring endocrineactive substances in the human diet in relation to human health. Nutrition 16 (2000) 654-687
15. Mousa N.A., Bedaiwy M.A., and Casper R.F. Aromatase inhibitors in the treatment of severe endometriosis. Obstet. Gynecol. 109 6 (2007) 1421-1423
16. Myllymaki S., Haavisto T., Vainio M., Toppari J., and Paranko J. In vitro effects of diethylstilbestrol, genistein, 4-tert-butylphenol, and 4-tertoctylphenol on steroidogenic activity of isolated immature rat ovarian follicles. Toxicol. Appl. Pharmacol. 204 1 (2005) 69-80
17. Noble L.S., Simpson E.R., Johns A., and Bulun S.E. Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 81 1 (1996) 174-179
18. Overstreet D.H., Keung W.M., Rezvani A.H., Massi M., and Lee D.Y. Herbal remedies for alcoholism: promises and possible pitfalls. Alcohol. Clin. Exp. Res. 27 2 (2003) 177-185
19. Ranney B. Etiology, prevention and inhibition of endometriosis. Clin. Obstet. Gynecol. 23 3 (1980) 875-881
20. Rice S., Mason H.D., and Whitehead S.A. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J. Steroid Biochem. Mol. Biol. 101 4-5 (2006) 216-225
21. arom (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol. Sci. 82 1 (2004) 70-79
22. Tsuchiya M., Miura T., Hanaoka T., Iwasaki M., Sasaki H., Tanaka T., Nakao H., Katoh T., Ikenoue T., Kabuto M., and Tsugane S. Effect of soy isoflavones on endometriosis: interaction with estrogen receptor 2 gene polymorphism. Epidemiology 18 3 (2007) 402-408
23. Wolters M., and Hahn A. Soy isoflavones - a therapy for menopausal symptoms?. Wien. Med. Wochenschr. 154 13-14 (2004) 334-341
24. Xiong F.L., Sun X.H., Gan L., Yang X.L., and Xu H.B. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur. J. Pharmacol. 529 1-3 (2006) 1-7
25. Xu M.E., Xiao S.Z., Sun Y.H., Zheng X.X., Ou-Yang Y., and Guan C. The study of anti-metabolic syndrome effect of puerarin in vitro. Life Sci. 77 25 (2005) 3183-3196
26. Xu X., Zhang S., Zhang L., Yan W., and Zheng X. The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 71 7 (2005) 585-591
27. Yan L.P., Chan S.W., Chan A.S., Chen S.L., Ma X.J., and Xu H.X. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci. 79 4 (2006) 324-333
28. Yeung D.K., Leung S.W., Xu Y.C., Vanhoutte P.M., and Man R.Y. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur. J. Pharmacol. 552 1-3 (2006) 105-111
29. Zhang S., Ji G., and Liu J. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J. Nutr. Biochem. 17 7 (2006) 485-491